Annual EBITDA
$4.67 B
+$650.00 M+16.19%
31 December 2023
Summary:
CME annual earnings before interest, taxes, depreciation & amortization is currently $4.67 billion, with the most recent change of +$650.00 million (+16.19%) on 31 December 2023. During the last 3 years, it has risen by +$1.31 billion (+39.16%). CME annual EBITDA is now at all-time high.CME EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
$1.30 B
+$22.20 M+1.74%
30 September 2024
Summary:
CME quarterly earnings before interest, taxes, depreciation & amortization is currently $1.30 billion, with the most recent change of +$22.20 million (+1.74%) on 30 September 2024. Over the past year, it has increased by +$198.80 million (+18.04%). CME quarterly EBITDA is now at all-time high.CME Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
$4.95 B
+$198.80 M+4.18%
30 September 2024
Summary:
CME TTM earnings before interest, taxes, depreciation & amortization is currently $4.95 billion, with the most recent change of +$198.80 million (+4.18%) on 30 September 2024. Over the past year, it has increased by +$459.00 million (+10.22%). CME TTM EBITDA is now at all-time high.CME TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CME EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +16.2% | +18.0% | +10.2% |
| 3 y3 years | +39.2% | +5.4% | +34.3% |
| 5 y5 years | +46.5% | +46.6% | +46.9% |
CME EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +39.2% | at high | +39.0% | at high | +34.3% |
| 5 y | 5 years | at high | +46.5% | at high | +86.9% | at high | +59.6% |
| alltime | all time | at high | >+9999.0% | at high | +3814.2% | at high | >+9999.0% |
CME EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.30 B(+1.7%) | $4.95 B(+4.2%) |
| June 2024 | - | $1.28 B(+3.2%) | $4.75 B(+2.9%) |
| Mar 2024 | - | $1.24 B(+9.4%) | $4.62 B(-1.0%) |
| Dec 2023 | $4.67 B(+16.2%) | $1.13 B(+2.7%) | $4.67 B(+3.9%) |
| Sept 2023 | - | $1.10 B(-3.8%) | $4.49 B(+2.1%) |
| June 2023 | - | $1.15 B(-10.9%) | $4.40 B(+3.5%) |
| Mar 2023 | - | $1.29 B(+34.2%) | $4.25 B(+5.8%) |
| Dec 2022 | $4.02 B(+2.3%) | $957.80 M(-5.2%) | $4.02 B(+0.6%) |
| Sept 2022 | - | $1.01 B(+1.4%) | $3.99 B(-5.3%) |
| June 2022 | - | $996.70 M(-5.1%) | $4.22 B(+3.2%) |
| Mar 2022 | - | $1.05 B(+12.3%) | $4.08 B(+4.0%) |
| Dec 2021 | $3.93 B(+17.1%) | $935.70 M(-24.2%) | $3.93 B(+6.5%) |
| Sept 2021 | - | $1.23 B(+42.8%) | $3.69 B(+17.1%) |
| June 2021 | - | $864.30 M(-3.1%) | $3.15 B(+1.5%) |
| Mar 2021 | - | $892.00 M(+27.9%) | $3.10 B(-7.5%) |
| Dec 2020 | $3.35 B(+0.4%) | $697.20 M(+0.1%) | $3.35 B(-2.5%) |
| Sept 2020 | - | $696.20 M(-14.7%) | $3.44 B(-5.3%) |
| June 2020 | - | $816.50 M(-28.6%) | $3.63 B(-1.4%) |
| Mar 2020 | - | $1.14 B(+46.1%) | $3.68 B(+10.2%) |
| Dec 2019 | $3.34 B(+4.9%) | $782.20 M(-11.8%) | $3.34 B(-0.9%) |
| Sept 2019 | - | $887.20 M(+2.0%) | $3.37 B(+7.2%) |
| June 2019 | - | $869.60 M(+8.4%) | $3.14 B(+0.9%) |
| Mar 2019 | - | $801.90 M(-1.2%) | $3.12 B(-2.2%) |
| Dec 2018 | $3.18 B(+11.7%) | $811.90 M(+22.9%) | $3.18 B(+5.2%) |
| Sept 2018 | - | $660.70 M(-21.4%) | $3.03 B(-0.9%) |
| June 2018 | - | $841.00 M(-3.4%) | $3.05 B(+4.2%) |
| Mar 2018 | - | $870.60 M(+32.8%) | $2.93 B(+2.8%) |
| Dec 2017 | $2.85 B(+8.2%) | $655.40 M(-4.6%) | $2.85 B(-1.0%) |
| Sept 2017 | - | $687.10 M(-4.5%) | $2.88 B(+1.8%) |
| June 2017 | - | $719.10 M(-9.0%) | $2.83 B(+2.4%) |
| Mar 2017 | - | $790.20 M(+15.6%) | $2.76 B(+4.7%) |
| Dec 2016 | $2.64 B(+14.5%) | $683.60 M(+7.6%) | $2.64 B(+5.2%) |
| Sept 2016 | - | $635.10 M(-2.5%) | $2.51 B(+1.3%) |
| June 2016 | - | $651.50 M(-2.2%) | $2.47 B(+4.9%) |
| Mar 2016 | - | $666.20 M(+20.3%) | $2.36 B(+2.3%) |
| Dec 2015 | $2.30 B(+8.4%) | $553.70 M(-8.0%) | $2.30 B(-0.2%) |
| Sept 2015 | - | $602.00 M(+12.5%) | $2.31 B(+3.9%) |
| June 2015 | - | $535.00 M(-12.6%) | $2.22 B(+1.1%) |
| Mar 2015 | - | $612.10 M(+9.5%) | $2.20 B(+3.4%) |
| Dec 2014 | $2.12 B(+6.7%) | $558.90 M(+8.4%) | $2.12 B(+7.8%) |
| Sept 2014 | - | $515.80 M(+1.2%) | $1.97 B(+1.1%) |
| June 2014 | - | $509.90 M(-5.5%) | $1.95 B(-4.7%) |
| Mar 2014 | - | $539.40 M(+33.0%) | $2.04 B(+2.7%) |
| Dec 2013 | $1.99 B(-4.2%) | $405.50 M(-17.9%) | $1.99 B(-2.5%) |
| Sept 2013 | - | $494.10 M(-18.4%) | $2.04 B(+0.4%) |
| June 2013 | - | $605.80 M(+24.9%) | $2.03 B(+0.1%) |
| Mar 2013 | - | $485.10 M(+6.1%) | $2.03 B(-2.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2012 | $2.08 B(-10.2%) | $457.30 M(-6.0%) | $2.08 B(-0.4%) |
| Sept 2012 | - | $486.70 M(-19.5%) | $2.09 B(-6.9%) |
| June 2012 | - | $604.50 M(+14.0%) | $2.24 B(+0.1%) |
| Mar 2012 | - | $530.20 M(+14.0%) | $2.24 B(-3.3%) |
| Dec 2011 | $2.31 B(+9.1%) | $465.00 M(-27.4%) | $2.31 B(-2.6%) |
| Sept 2011 | - | $640.30 M(+6.2%) | $2.38 B(+5.5%) |
| June 2011 | - | $602.70 M(-0.5%) | $2.25 B(+0.9%) |
| Mar 2011 | - | $605.90 M(+15.0%) | $2.23 B(+5.3%) |
| Dec 2010 | $2.12 B(+16.3%) | $526.70 M(+1.9%) | $2.12 B(+3.7%) |
| Sept 2010 | - | $517.10 M(-11.3%) | $2.04 B(+3.3%) |
| June 2010 | - | $583.10 M(+18.2%) | $1.98 B(+6.2%) |
| Mar 2010 | - | $493.30 M(+9.5%) | $1.86 B(+2.2%) |
| Dec 2009 | $1.82 B(+14.5%) | $450.50 M(-0.1%) | $1.82 B(+14.5%) |
| Sept 2009 | - | $450.90 M(-3.7%) | $1.59 B(-3.3%) |
| June 2009 | - | $468.40 M(+3.2%) | $1.65 B(+4.5%) |
| Mar 2009 | - | $453.70 M(+106.5%) | $1.58 B(+0.1%) |
| Dec 2008 | $1.59 B(+30.6%) | $219.70 M(-56.6%) | $1.57 B(-9.6%) |
| Sept 2008 | - | $506.00 M(+27.5%) | $1.74 B(+6.6%) |
| June 2008 | - | $396.79 M(-12.1%) | $1.63 B(+12.1%) |
| Mar 2008 | - | $451.37 M(+16.6%) | $1.46 B(+18.8%) |
| Dec 2007 | $1.22 B(+75.1%) | $387.00 M(-2.9%) | $1.23 B(+20.5%) |
| Sept 2007 | - | $398.36 M(+81.1%) | $1.02 B(+27.9%) |
| June 2007 | - | $219.95 M(-0.6%) | $795.54 M(+3.7%) |
| Mar 2007 | - | $221.19 M(+24.1%) | $766.97 M(+9.2%) |
| Dec 2006 | $696.18 M(+27.5%) | $178.28 M(+1.2%) | $702.58 M(+6.9%) |
| Sept 2006 | - | $176.13 M(-8.0%) | $657.42 M(+6.2%) |
| June 2006 | - | $191.38 M(+22.1%) | $618.98 M(+4.2%) |
| Mar 2006 | - | $156.80 M(+17.8%) | $593.76 M(+5.1%) |
| Dec 2005 | $545.85 M(+32.4%) | $133.12 M(-3.3%) | $564.70 M(+9.1%) |
| Sept 2005 | - | $137.69 M(-17.1%) | $517.42 M(+3.9%) |
| June 2005 | - | $166.16 M(+30.1%) | $498.07 M(+11.5%) |
| Mar 2005 | - | $127.73 M(+48.8%) | $446.67 M(+8.3%) |
| Dec 2004 | $412.35 M(+59.1%) | $85.83 M(-27.5%) | $412.35 M(+7.6%) |
| Sept 2004 | - | $118.34 M(+3.1%) | $383.05 M(+15.0%) |
| June 2004 | - | $114.75 M(+22.8%) | $333.17 M(+13.7%) |
| Mar 2004 | - | $93.42 M(+65.2%) | $293.01 M(+13.1%) |
| Dec 2003 | $259.14 M(+15.2%) | $56.53 M(-17.4%) | $259.14 M(-2.3%) |
| Sept 2003 | - | $68.46 M(-8.2%) | $265.29 M(+6.1%) |
| June 2003 | - | $74.59 M(+25.3%) | $249.92 M(+9.0%) |
| Mar 2003 | - | $59.55 M(-5.0%) | $229.31 M(+8.1%) |
| Dec 2002 | $224.88 M(+39.3%) | $62.68 M(+18.0%) | $212.14 M(+14.3%) |
| Sept 2002 | - | $53.10 M(-1.6%) | $185.59 M(+4.1%) |
| June 2002 | - | $53.98 M(+27.4%) | $178.21 M(+13.2%) |
| Mar 2002 | - | $42.38 M(+17.3%) | $157.46 M(+36.8%) |
| Dec 2001 | $161.48 M(+535.6%) | $36.13 M(-21.0%) | $115.08 M(+45.8%) |
| Sept 2001 | - | $45.72 M(+37.5%) | $78.96 M(+137.5%) |
| June 2001 | - | $33.24 M | $33.24 M |
| Dec 2000 | $25.41 M | - | - |
FAQ
- What is CME annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for CME?
- What is CME annual EBITDA year-on-year change?
- What is CME quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for CME?
- What is CME quarterly EBITDA year-on-year change?
- What is CME TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for CME?
- What is CME TTM EBITDA year-on-year change?
What is CME annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of CME is $4.67 B
What is the all time high annual EBITDA for CME?
CME all-time high annual earnings before interest, taxes, depreciation & amortization is $4.67 B
What is CME annual EBITDA year-on-year change?
Over the past year, CME annual earnings before interest, taxes, depreciation & amortization has changed by +$650.00 M (+16.19%)
What is CME quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of CME is $1.30 B
What is the all time high quarterly EBITDA for CME?
CME all-time high quarterly earnings before interest, taxes, depreciation & amortization is $1.30 B
What is CME quarterly EBITDA year-on-year change?
Over the past year, CME quarterly earnings before interest, taxes, depreciation & amortization has changed by +$198.80 M (+18.04%)
What is CME TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of CME is $4.95 B
What is the all time high TTM EBITDA for CME?
CME all-time high TTM earnings before interest, taxes, depreciation & amortization is $4.95 B
What is CME TTM EBITDA year-on-year change?
Over the past year, CME TTM earnings before interest, taxes, depreciation & amortization has changed by +$459.00 M (+10.22%)